Atrial Fibrillation (AFib) clinical trials in Kansas
17 active Atrial Fibrillation (AFib) trials with a site in Kansas. Describe your situation to see which ones look like a fit.
- A Study of VARIPULSE Catheter in Participants With Persistent Atrial Fibrillation Undergoing Pulmonary Vein and Superior Vena Cava Isolation
- Coherent Sine Burst Electroporation (CSE) Ablation System US IDE Study for Patients With Atrial Fibrillation
- The Fourth Left Atrial Appendage Occlusion Study
- A Study Assessing Long-Term Safety and Effectiveness in Treatment Management of Atrial Fibrillation With VARIPULSE Catheter System
- A Study of VARIPULSE Pulsed Field Ablation (PFA) Catheter and FARAWAVE PFA Catheter in the Treatment of Participants With Persistent Atrial Fibrillation
- Study to evaLuate the effIcacy and Safety of abeLacimab in High-risk Patients With Atrial Fibrillation Who Have Been Deemed Unsuitable for Oral antiCoagulation (LILAC-TIMI 76)
- The CONFORM Pivotal Trial
- Anticoagulation in ICH Survivors for Stroke Prevention and Recovery
- Long-Term Outcomes of LAA Contrast Flow in CT Scans After Endocardial LAA Closure: The CF-CT Registry
- Clinical and Healthcare Outcomes From Real-World Use in the United States of a Companion AI During AF Ablation
- Observational Study to Examine the Procedural and Outcomes of AF Ablation Assisted by STAR Apollo™ Mapping System
- Tracking Results of Ablations to Combat AF Registry Generation 2
- Use of 4D-ICE in Conjunction With TEE for Left Atrial Appendage Closure
- Vascular Closure With a Device Compared to Manual Compression After Atrial Fibrillation Ablation: The LockeT II Study
- Assessing the Neurological Outcomes After Atrial Fibrillation Ablation for Rhythm Control
- Impact of Intravenous Caffeine on Atrial Electrical Properties and Potential Arrythmia Induction
- Impact of Steerable Delivery Sheaths on Successful Closure of LA A With AMULET
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.